Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events (Q71827242)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 November 1995

Language	Label	Description	Also known as
English	Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events	scientific article published on 01 November 1995

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594023%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594023%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events (English)

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Stephen G. Ellis

3

object named as

S G Ellis

1 reference

Europe PubMed Central

PubMed publication ID

21 October 2019

author name string

B. Pitt

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594023

2 June 2024

G. B. Mancini

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594023

2 June 2024

H. S. Rosman

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594023

2 June 2024

J. S. Park

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594023

2 June 2024

M. E. McGovern

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594023

2 June 2024

language of work or name

0 references

publication date

1 November 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594023%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

full work available at URL

https://api.elsevier.com/content/article/PII:0735109795003010?httpAccept=text/xml

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

https://api.elsevier.com/content/article/PII:0735109795003010?httpAccept=text/plain

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594023%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594023%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594023%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1133-1139

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594023%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Design and recruitment in the United States of a multicenter quantitative angiographic trial of pravastatin to limit atherosclerosis in the coronary arteries (PLAC I).

1

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

3

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

4

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

6

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

7

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Automated quantitative coronary arteriography: morphologic and physiologic validation in vivo of a rapid digital angiographic method

9

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

11

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Prognostic significance of progression of coronary atherosclerosis

12

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

14

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

15

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

16

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

17

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?

19

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Progression of coronary atherosclerosis: is coronary spasm related to progression?

20

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Angiographic progression of coronary artery disease and the development of myocardial infarction

21

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Long-term prognosis of medically treated patients with acute myocardial infarction and one-vessel coronary artery disease.

22

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

23

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Pravastatin, lipids, and major coronary events

24

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

25

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension

26

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

27

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

28

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients

29

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

30

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases

31

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Platelet aggregation, coronary artery disease progression and future coronary events

33

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease

34

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

36

1 reference

10.1016/0735-1097(95)00301-0

https://api.crossref.org/works/10.1016/0735-1097(95)00301-0

2 June 2024

Identifiers

10.1016/0735-1097(95)00301-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594023%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594023%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71827242&oldid=2170562113"